Tenascin XB (TNXB) |
Chr 6: 31, 998, 796-32, 043, 729 |
3125 |
58.44 |
ADAM metallopeptidase domain 19 (ADAM19) |
Chr 5: 157, 395, 534-157, 575, 775 |
2823 |
84.39 |
Pleckstrin homology like domain family A member 1 (PHLDA1) |
Chr 12: 76, 025, 447-76, 033, 932 |
5741 |
142.55 |
Nebulette (NEBL) |
Chr 10: 20, 779, 973-21, 174, 187 |
9216 |
72.12 |
Thrombomodulin (THBD) |
Chr 20: 23, 045, 633-23, 049, 741 |
4109 |
157.58 |
Matrix remodeling associated 5 (MXRA5) |
Chr X: 3, 308, 565-3, 346, 652 |
9804 |
64.88 |
Glutaminyl-peptide cyclotransferase (QPCT) |
Chr 2: 37, 342, 827-37, 373, 322 |
582 |
87.48 |
cAMP responsive element binding protein 5 (CREB5) |
Chr 7: 28, 299, 321-28, 825, 894 |
2294 |
82.74 |
ATP binding cassette subfamily G member 2 (ABCG2) |
Chr 4: 88, 090, 150-88, 231, 628 |
4844 |
174.35 |
Microfibrillar associated protein 4 (MFAP4) |
Chr 17: 19, 383, 442-19, 387, 240 |
1876 |
94.03 |
Coiled-coil domain containing 3 (CCDC3) |
Chr 10: 12, 896, 625-13, 099, 652 |
2747 |
45.16 |
Sprouty RTK signaling antagonist 1 (SPRY1) |
Chr 4: 123, 396, 795-123, 403, 760 |
641 |
99.85 |
JunB proto-oncogene, AP-1 transcription factor subunit (JUNB) |
Chr 19: 12, 791, 486-12, 793, 315 |
1830 |
183.24 |
Cartilage oligomeric matrix protein (COMP) |
Chr 19: 18, 782, 773-18, 791, 305 |
2707 |
66.76 |
Coagulation factor II thrombin receptor (F2R) |
Chr 5: 76, 716, 126-76, 735, 770 |
3727 |
141.45 |
RAS-like family 11 member B (RASL11B) |
Chr 4: 52, 862, 317-52, 866, 835 |
1968 |
104.94 |
Suppressor of cytokine signaling 2 (SOCS2) |
Chr 12: 93, 569, 814-93, 583, 487 |
2761 |
126.91 |
Alcohol dehydrogenase 1B (class I), beta polypeptide (ADH1B) |
Chr 4: 99, 304, 971-99, 352, 760 |
4067 |
56.58 |
Follistatin like 3 (FSTL3) |
Chr 19: 676, 392-683, 392 |
2501 |
72.62 |
Peptidase inhibitor 16 (PI16) |
Chr 6: 36, 948, 263-36, 964, 837 |
2288 |
50.86 |
Transforming growth factor beta induced (TGFBI) |
Chr 5: 136, 028, 988-136, 063, 818 |
2712 |
158.86 |
HOP homeobox (HOPX) |
Chr 4: 56, 647, 988-56, 681, 899 |
1123 |
112.52 |